Back to Search
WALLACE KOWALCZYK, MD
MD
Anesthesiology Physician
NPI: 1720173875Individual
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
D0016741(MD)
Research & Publications (20)
Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.
PMID 19461298·Anesthesiology·2009
7-preclinical
Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers.
PMID 17581533·Neuropsychopharmacology·2008
4-observational
The effects of N-terminal part modification of arginine vasopressin analogues with 2-aminoindane-2-carboxylic acid: a highly potent V2 agonist.
PMID 17500550·J Med Chem·2007
7-preclinical
Structure-activity relationship of CART (cocaine- and amphetamine-regulated transcript) peptide fragments.
PMID 17766010·Peptides·2007
7-preclinical
Sequencing batch reactor (SBR) as optimal method for production of granular activated sludge (GAS)--fluid dynamic investigations.
PMID 17546981·Water Sci Technol·2007
8-other
Investigation of cis/trans ratios of peptide bonds in AVP analogues containing N-methylphenylalanine enantiomers.
PMID 15959924·J Pept Sci·2006
4-observational
Sex differences and hormonal influences on response to cold pressor pain in humans.
PMID 16516820·J Pain·2006
8-other
Analogues of neurohypophyseal hormones, oxytocin and arginine vasopressin, conformationally restricted in the N-terminal part of the molecule.
PMID 16539389·J Med Chem·2006
7-preclinical
New bradykinin analogues substituted in positions 7 and 8 with sterically restricted 1-aminocyclopentane-1-carboxylic acid.
PMID 17131289·J Pept Sci·2006
7-preclinical
Analogues of arginine vasopressin and its agonist and antagonist modified in the N-terminal part of the molecule with l-beta-homophenylalanine.
PMID 15813895·J Pept Res·2005
7-preclinical
New bradykinin analogues modified in the C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid.
PMID 16335929·J Med Chem·2005
7-preclinical
Analogues of arginine vasopressin modified in position 2 and 3 with conformationally constrained dipeptide fragments.
PMID 15635636·J Pept Sci·2005
7-preclinical
Influence of enantiomers of 1-naphthylalanine in position 2 of VAVP and dVAVP on their pharmacological properties.
PMID 15642410·Eur J Med Chem·2005
7-preclinical
New acylated bradykinin analogues: effect on rat blood pressure and rat uterus.
PMID 15742339·J Pept Sci·2005
7-preclinical
The influence of 1-aminocyclopentane-1-carboxylic acid at position 2 or 3 of AVP and its analogues on their pharmacological properties.
PMID 15747318·J Pept Sci·2005
7-preclinical
Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.
PMID 15537356·J Med Chem·2004
7-preclinical
Analogues of arginine vasopressin modified in the N-terminal part of the molecule with enantiomers of N-methylphenylalanine.
PMID 15140159·J Pept Res·2004
7-preclinical
Cis/trans conformational equilibrium across the N-methylphenylalanine- N-methylphenylalanine peptide bond of arginine vasopressin analogs.
PMID 15102051·J Pept Res·2004
8-other
Potent bradykinin antagonists containing N-benzylglycine or N-benzyl-l-alanine in position 8.
PMID 14984571·J Pept Res·2004
7-preclinical
Influence of 1-aminocyclohexane-1-carboxylic acid in position 2 or 3 of AVP and its analogues on their pharmacological properties.
PMID 12823619·J Pept Res·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5401 OLD COURT RD
RANDALLSTOWN, MD 21133 - Phone
- (410) 521-2200
Quick Facts
- NPI
- 1720173875
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile